市場調查報告書
商品編碼
1467994
數位病理檢測市場:按產品類型、應用和最終用戶分類 - 2024-2030 年全球預測Digital Pathology Market by Product (Scanners, Software, Storage Systems), Type (Human Pathology, Veterinary Pathology), Application, End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年數位病理檢測市場規模為18.5億美元,預計2024年將達21.1億美元,2030年將達到48.1億美元,複合年成長率為14.58%。
數位病理學是指在數位環境中捕獲、管理、共用和解釋病理訊息,包括幻燈片和資料。數位病理檢測旨在提高病理評估的效率和準確性,促進醫學領域診斷、研究和教育方面更好的決策。它利用先進的影像處理技術、電腦演算法和資料分析技術,更準確、更全面地檢查組織樣本,使病理學家能夠更清晰、更詳細地檢測疾病和狀況。由於慢性病盛行率不斷上升,對高品質診斷的需求不斷成長,並促進遠距醫療提供快速、準確的分析並改善患者預後,數位病理測試市場正在快速成長。然而,市場受到顯著障礙的困擾,包括系統整合挑戰,以及與實施數位系統相關的高成本和資料安全問題。儘管存在這些障礙,人工智慧(AI)和用於分析自動化的機器學習、隨著醫療基礎設施的發展而擴展到新興市場以及增加全球研究合作的潛力仍然存在快速成長的機會,顯示出巨大的成長前景。這種市場格局代表了一個正在經歷重大演變的市場,預計將重新定義病理診斷和醫療保健服務。
主要市場統計 | |
---|---|
基準年[2023] | 18.5億美元 |
預測年份 [2024] | 21.1億美元 |
預測年份 [2030] | 48.1億美元 |
複合年成長率(%) | 14.58% |
擴大轉向雲端基礎的解決方案,以獲得比產品更靈活、更具成本效益的儲存選項
數位病理掃描儀是一種先進的設備,用於透過捕捉高解析度影像將傳統玻璃載玻片轉換為數位載玻片。實驗室可以根據吞吐量需求、解析度要求以及通常處理的檢體類型來選擇掃描器。高通量掃描器是標準實驗室和學術中心等大批量檢體環境中的首選,而較小的診所可能會選擇緊湊、低通量的型號。數位病理學測試中包含的軟體包括影像分析工具、工作流程管理系統和遠端病理學解決方案。這些解決方案可實現詳細分析、遠端存取和高效的案例管理,從而增加數位投影片的價值。數位病理測試會產生大量資料,需要強大的儲存解決方案。根據業務規模、資料安全要求和可存取性需求選擇儲存解決方案。較大的機構可能需要高度擴充性的雲端基礎的解決方案,而較小的實驗室可能會選擇初始成本較低的小型資料庫系統。
應用 更多採用數位病理學測試,以提高識別潛在治療標靶和了解疾病機制的速度和準確性
數位病理學測試在疾病診斷中的應用使病理學家透過數位化玻片並使用數位影像進行分析,能夠更準確、更有效率地診斷包括癌症在內的疾病。這種模式支持各種診斷程序,包括分析癌細胞、對腫瘤樣本進行分級和監測疾病進展。數位病理測試在藥物發現過程中發揮重要作用,特別是在藥物療效評估和毒性測試中。透過對組織樣本進行數字分析,研究人員可以在微觀層面上更好地了解候選藥物的作用。數位病理學測試透過提供大量數位幻燈片進行教學和協作學習,徹底改變了病理學教育和培訓。學生和學員可以遠端查看、註釋和討論數位幻燈片,消除醫學教育中的地理障礙。該細分市場的一個關鍵要求是存取綜合數位幻燈片庫和互動式學習工具,以促進遠端教育和協作培訓計劃。
區域洞察
在先進技術的高採用率、完善的醫療基礎設施以及該地區主要市場參與者的推動下,美洲的數位病理檢測市場正在呈現顯著成長。此外,FDA 監管部門的核准刺激了數位病理測試系統用於初級診斷的採用,從而促進了市場成長。在 EMEA(歐洲、中東和非洲)地區,隨著歐洲各地對數位化病理診斷優勢的認知不斷增強,對數位病理測試解決方案的需求強勁。尤其是西歐,由於該地區強大的醫療保健系統以及醫療保健 IT 投資的增加,該地區的採用率尤其高。在持續的醫療保健現代化舉措的推動下,中東和非洲正在經歷適度成長。由於慢性病的增加、醫療保健支出的增加以及對數位病理檢測益處的認知不斷增強,預計亞太地區將擴大採用數位病理檢測解決方案。由於病理實驗室數量的增加和研發活動的擴大,亞太地區的需求進一步增強。
FPNV定位矩陣
FPNV定位矩陣對於評估數位病理檢測市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對數位病理測試市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,以獲得市場競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4. 競爭評估和情報:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.數位病理檢測市場規模及預測是多少?
2.在數位病理檢測市場的預測期內,有哪些產品、細分市場、應用程式和領域需要考慮投資?
3.數位病理檢測市場的技術趨勢和法規結構是什麼?
4.數位病理檢測市場主要廠商的市場佔有率為何?
5.進入數位病理檢測市場合適的型態和策略手段是什麼?
[197 Pages Report] The Digital Pathology Market size was estimated at USD 1.85 billion in 2023 and expected to reach USD 2.11 billion in 2024, at a CAGR 14.58% to reach USD 4.81 billion by 2030.
Digital pathology refers to acquiring, managing, sharing, and interpreting pathology information, including slides and data, in a digital environment. Digital pathology aims to enhance the efficiency and accuracy of pathological assessments, fostering better decision-making in diagnostics, research, and education within the medical field. It leverages advanced imaging technology, computer algorithms, and data analysis techniques to facilitate a more precise and comprehensive examination of tissue samples, enabling pathologists to detect diseases and conditions with improved clarity and detail. The digital pathology market is growing rapidly, owing to the growing need for high-quality diagnostics amid rising chronic disease prevalence, offering rapid, precise analysis and facilitating remote consultations to improve patient outcomes. However, the market grapples with notable hurdles, including the high costs associated with adopting digital systems and concerns over data security, alongside challenges in system integration. Despite these obstacles, burgeoning opportunities in artificial intelligence (AI) and machine learning for analysis automation, the expansion into emerging markets with developing healthcare infrastructure, and the potential for enhanced global research collaboration present significant growth prospects. This landscape illustrates a market poised for substantial evolution, promising to redefine pathological diagnostics and healthcare delivery.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 1.85 billion |
Estimated Year [2024] | USD 2.11 billion |
Forecast Year [2030] | USD 4.81 billion |
CAGR (%) | 14.58% |
Product: Growing shift towards cloud-based solutions for more flexible and cost-effective storage options
Digital pathology scanners are sophisticated devices used to convert traditional glass slides into digital slides by capturing high-resolution images. Laboratories may choose scanners based on their throughput needs, resolution requirements, and the types of specimens they commonly handle. High-throughput scanners are preferred in settings with large volumes of samples, such as in reference laboratories and academic centers, whereas smaller clinics might opt for compact, lower-throughput models. Software in digital pathology includes image analysis tools, workflow management systems, and telepathology solutions. These solutions enhance the value of digital slides by enabling detailed analysis, remote access, and efficient case management. Digital pathology generates vast amounts of data, necessitating robust storage solutions. Storage solutions are chosen based on the size of the operation, data security requirements, and accessibility needs. Larger institutions may need scalable cloud-based solutions, whereas smaller labs might opt for local storage systems with lower initial costs.
Application: Rising adoption of digital pathology to enhance the speed and accuracy of identifying potential therapeutic targets and understanding disease mechanisms
The application of digital pathology in disease diagnosis involves digitizing glass slides and using digital images for analysis, thus enabling pathologists to diagnose diseases, including cancer, more accurately and efficiently. This modality supports a diverse range of diagnostic procedures, including the analysis of cancerous cells, the grading of tumor samples, and the monitoring of disease progression. Digital pathology has a crucial role in the drug discovery process, particularly in the evaluation of drug efficacy and toxicology studies. By enabling the digital analysis of tissue samples, researchers can better understand the effects of drug candidates at the microscopic level. Digital pathology has revolutionized pathology education and training by offering access to a vast array of digital slides for teaching and collaborative learning. Students and trainees can view, annotate, and discuss digital slides remotely, breaking down geographical barriers in medical education. The primary requirement of this segment is the accessibility of comprehensive digital slide libraries and interactive learning tools that facilitate remote education and collaborative training programs.
Regional Insights
The digital pathology market in the Americas has shown significant growth, attributed to several factors, including the high adoption of advanced technologies, well-established healthcare infrastructure, and the presence of major market players in the region. Furthermore, regulatory approvals by the FDA have spurred the adoption of digital pathology systems for primary diagnostics, contributing to market growth. The EMEA region exhibits a robust demand for digital pathology solutions, driven by the growing awareness of the benefits of digitalization in pathology across Europe. Western Europe, in particular, demonstrates a high adoption rate owing to the region's strong healthcare systems and increasing investments in healthcare IT. The Middle East and Africa are witnessing gradual growth fueled by ongoing healthcare modernization initiatives. Asia-Pacific is anticipated to adopt digital pathology solutions more owing to the rising prevalence of chronic diseases, increasing healthcare expenditure, and growing awareness of digital pathology's benefits. The demand in APAC is further bolstered by the growing number of pathology laboratories and expanding research and development activities.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Digital Pathology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Digital Pathology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Digital Pathology Market, highlighting leading vendors and their innovative profiles. These include 3DHISTECH Ltd., Aiforia Technologies PLC, Charles River Laboratories, Corista LLC, DeepBio, Inc., Epredia, F. Hoffmann-La Roche Ltd., FUJIFILM Holdings Corporation, GE Healthcare, Hamamatsu Photonics K.K., Huron Digital Pathology, Indica Labs, Koninklijke Philips N.V., Laboratory Corporation of America Holdings, Leica Biosystems Nussloch GmbH, Mikroscan Technologies, Motic, Nikon Corporation, OptraSCAN, Inc., PathAI, Pathcore Inc., PathPresenter Corporation, PerkinElmer, Inc., Proscia, Inc., Sectra AB, Visiopharm A/S, and Xybion Digital Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Digital Pathology Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Digital Pathology Market?
3. What are the technology trends and regulatory frameworks in the Digital Pathology Market?
4. What is the market share of the leading vendors in the Digital Pathology Market?
5. Which modes and strategic moves are suitable for entering the Digital Pathology Market?